An interventional study of Delivery and return of chocolate and Determination of blood pressure in Hypertension, sponsored by Universidad de Antioquia. Completed at 1 site in Colombia. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-01-24.
Sponsored by Universidad de Antioquia · Not applicable, Interventional, and Treatment
In Colombia, ischemic heart disease and stroke are one of the most important causes of death in 45 years old people. Care of cases of disease represents high costs for the health system in particular and society in general, due to the loss of productive years life and costs for the care of the aftermath. Hypertension (HT) is one of the preventable risk factors for major cerebrovascular disorders. The pathophysiology of Essential hypertension is complex and depends of interaction of genetic and environmental factors. Among the determining elements are the increase in the activity of the sympathetic nervous system, the vasoconstricting and overproduction of hormones associated with sodium retention, disruption in renin secretion with increased production of aldosterone and angiotensin II, the deregulation of the kinins system, the increase in peripheral vascular resistance and activity of Growth factors in atherogenesis and vascular endothelial dysfunction, increased cardiac output, diabetes mellitus, obesity, and lower production of vasodilators such as brain natriuretic peptide (BNP), the prostacyclins and nitric oxide (NO), among others.
Cocoa is a food rich in flavonoids, which stimulate the enzyme activity of endothelial nitric oxide synthase (e-NOS), responsible of the production of NO in vascular smooth muscle. The flavonoids modulate the synthesis of inflammatory substances that are derived from endothelial cells and the immune system.
In a recent study found that with a few grams of cocoa achieves a significant reduction in blood pressure, so the investigators propose a controlled clinical trial to assess the effect of different doses of cocoa on blood pressure and endothelial inflammation in men with essential hypertension, stage I-II without target organ damage, in addition to pharmacologic monotherapy defined for the management of their disease. The investigators hope to determine an optimal dose of cocoa, with long-term effects, by their high content of flavonoids, improves cardiovascular and endothelial parameters with the advantage that it is an economical and easy introduction into the patient's habits.
6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.
This study's enrollment of 125 is above the median of 90 across 5,095 interventional studies indexed under Hypertension.
Browse Hypertension studies →Universidad de Antioquia is the lead sponsor of 80 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dietary Supplement: Delivery and return of chocolate · Procedure: Determination of blood pressure · Procedure: Anthropometric Measurements · Procedure: Food Anamnesis · Procedure: Samples: serological tests and culture of mononuclear cells · Procedure: Analysis of cytokine production
Dietary Supplement: Delivery and return of chocolate · Procedure: Determination of blood pressure · Procedure: Anthropometric Measurements · Procedure: Food Anamnesis · Procedure: Samples: serological tests and culture of mononuclear cells · Procedure: Analysis of cytokine production
Dietary Supplement: Delivery and return of chocolate · Procedure: Determination of blood pressure · Procedure: Anthropometric Measurements · Procedure: Food Anamnesis · Procedure: Samples: serological tests and culture of mononuclear cells · Procedure: Analysis of cytokine production
Dietary Supplement: Delivery and return of chocolate · Procedure: Determination of blood pressure · Procedure: Anthropometric Measurements · Procedure: Food Anamnesis · Procedure: Samples: serological tests and culture of mononuclear cells · Procedure: Analysis of cytokine production
Dietary Supplement: Delivery and return of chocolate · Procedure: Determination of blood pressure · Procedure: Anthropometric Measurements · Procedure: Food Anamnesis · Procedure: Samples: serological tests and culture of mononuclear cells · Procedure: Analysis of cytokine production
At baseline and then every 2 weeks, each participant will receive different grams of chocolate, according to the group to which he is assigned.
Blood pressure will be determined at study entry, ninth and eighteenth week taking into account the protocols established in 2007 by the European Society of Cardiology and Hypertension. Because blood pressure has variations throughout the day and that measuring ambulatory health institutions can generate emotional changes that induce changes in this clinical setting, which for purposes of this study is the main outcome variable, there will be 24-hour monitoring of blood pressure at the beginning and end of the study.
The study will be determined the body mass index (BMI) by the ratio of weight in kilograms over height in meters squared, for which anthropometric measurement will be made at first, ninth and the eighteenth week as follows: The weight will be taken with an electronic balance of 0.05 g sensitivity standing capacity of 150 kg. We will be rated based on BMI cut points given by WHO-PAHO (1993) and adopted by the Ministry of Health of Colombia (2000).
With the aim of learning about the eating habits, it will be made based on a food intake recall the last 24 hours, taking into account that is not preceded by a special food day (sundays, holidays, celebrations). For more accurately calculate nutrient ingested food, modules will be used.
At admission and at the end of the study will be obtained after 12 hours of fasting, 8 mL of blood in a dry tube without anticoagulant and 30 mL of blood in heparin tubes, properly labeled with the code assigned to the participant. The sample will be used to determine the complete lipid profile (triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol and VLDL cholesterol), State of oxidation of low density lipoprotein (oxLDL) and mononuclear cell culture. The remaining serum was kept at -20°C for use if is required repeat any study.
We will be used the supernatant of mononuclears cell culture to quantify the production of interleukin one beta, interleukin two, tumor necrosis factor alpha by ELISA with commercially available kits for this purpose.
Change on blood pressure in patients with stage I-II hypertension, after consumption of different doses of cocoa.
Time frame: 18 weeks
Change in the oxidation of low density lipoproteins after cocoa consumption, in patients with stage I-II hypertension.
Time frame: 18 weeks
Change in the production of inflammatory molecules derived from peripheral blood mononuclear cells of patients with arterial hypertension stage I-II, after cocoa consumption.
Time frame: 18 weeks
Change in platelet aggregation after cocoa consumption, in patients with essential arterial hypertension stage I-II.
Time frame: 18 weeks
Plan to share: No
This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de Antioquia